Champions Oncology Inc
Research Champions Oncology Inc (CSBR) on Bullrun: market cap USD 67.37M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCSBR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 67.37M
- Financial periodFY2026
- RevenueUSD 59.43M
- Revenue growth4.4%
- Net income-USD 1.18M
- Free cash flow-USD 5.04M
- Gross margin48.0%
Valuation Snapshot
latest market cap is USD 67.37M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 59.43M | -USD 1.18M | -USD 5.04M | 48.0% | -0.08 | USD 4.87M | USD 4.51M | USD 3.94M |
| FY2025 | USD 56.94M | USD 4.70M | USD 7.00M | 50.1% | 0.33 | USD 9.79M | USD 6.11M | USD 3.77M |
| FY2024 | USD 50.16M | -USD 7.28M | -USD 6.97M | 41.4% | -0.54 | USD 2.62M | USD 7.43M | -USD 1.90M |
| FY2023 | USD 53.87M | -USD 5.34M | USD 1.10M | 45.2% | -0.39 | USD 10.12M | USD 8.60M | USD 4.64M |
| FY2022 | USD 49.11M | USD 548.00K | USD 4.11M | 51.9% | 0.04 | USD 9.01M | USD 9.47M | USD 9.10M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 67.37M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 95.95M | 40.6 | n/a | n/a |
| 2024 | 2024-12-31 | USD 117.40M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 76.40M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 61.15M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 112.98M | 209.0 | n/a | n/a |
About Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Champions Oncology Inc's market cap?
Champions Oncology Inc's market capitalization is USD 67.37M.
What does Champions Oncology Inc do?
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies.